IL6 and allergic disease: Additionally, the study found that the IL-6 (− 174G/C) variant significantly correlates with a lower risk of childhood allergic diseases across different age groups, observed in multiple comparisons, including dominant, allele, heterozygote, and homozygote comparisons.